EcoDrugPlus

Ensembl ID : ENSCCRG00000001542
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSCCRG00000019933
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSCCRG00000002121
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSCCRG00000049387
Gene Symbol: -
Cross references: -
128 Possible Orthologues:

Ensembl ID : ENSCCRG00000060682
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSCCRG00000049388
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSCCRG00000049506
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSCCRG00000049315
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSCCRG00000061009
Gene Symbol: -
Cross references: -
143 Possible Orthologues:

Ensembl ID : ENSCCRG00000064000
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSCCRG00000049289
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSCCRG00000064048
Gene Symbol: YES1
1 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).